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Abstract 
Background: Nasopharyngeal carcinoma (NPC) is a malignant epithelial carcinoma of the head and neck with strong 
ability of invasion and metastasis. Our previous study indicated that miR-324-3p, as a tumor-suppressive factor, could 
regulate radioresistance of NPC cells by targeting WNT2B. The purpose of this study is to investigate the role of miR-
324-3p on migration and invasion in NPC cells.
Methods: Quantitative real time PCR was applied to measure the expression level of miR-324-3p and WNT2B mRNA 
in both cells and tissues, and the expression level of WNT2B protein was determined by western blotting. The capacity 
of migration and invasion were tested by using wound healing and transwell invasion assay.
Results: Ectopic expression of miR-324-3p or silencing its target gene WNT2B could dramatically suppress migration 
and invasion capacity of NPC cells. Meanwhile, the alterations of miR-324-3p in NPC cells could influence the expres-
sion level of the biomarkers of epithelial-mesenchymal transition (EMT), including E-cadherin and Vimentin. Moreover, 
the expression of miR-324-3p was obviously downregulated and WNT2B was significantly upregulated in NPC tissues. 
The expression levels of miR-324-3p and WNT2B were closely correlated with T stage, clinic stage and cervical lymph 
node metastasis of NPC (P < 0.05).
Conclusion: miR-324-3p could suppress the migration and invasion of NPC by targeting WNT2B and the miR-324-3p/
WNT2B pathway possibly provide new potential therapeutic clues for NPC.
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Background
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr 
virus associated cancer that mostly occurs in Southern 
China and South-Eastern Asia [1]. Despite great improve-
ments in chemoradiotherapy over the past few decades, 
the overall 5-year survival rate for NPC still remains poor 
[2]. Strong ability to migrate and invade is a leading cause 
for the dismay prognosis of advanced NPC patients [3]. 
For this reason, exploring the molecular mechanisms 
underlying NPC migration and invasion is essential for 
the development of novel therapeutic strategies.
microRNAs (miRNAs) are a kind of small non-pro-
tein-coding RNA, which consist of 19–25 nucleotides 
[4]. They can inhibit target gene expression at the post-
transcriptional level by pairing with the 3′ untranslated 
regions (3′ UTRs), 5′ UTRs or coding region of mRNAs 
[5, 6]. Accumulated evidences prove that dysregulated 
miRNAs can function as oncogenes or tumour suppres-
sors in the initiation and progression of various human 
cancers [7]. In NPC, miRNAs are also reported to play 
important regulatory roles in many critical biological 
processes including cell proliferation, apoptosis, radio-
sensitivity and chemosensitivity [8–10]. As to migration 
and invasion of NPC, a series of miRNAs like miR-145 or 
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miR-744 can inhibit or enhance NPC migration and inva-
sion by targeting SMAD3 or ARHGAP5, respectively [11, 
12]. These above findings indicated that miRNAs provide 
a new perspective for the investigation of migration and 
invasion in NPC.
In our preliminary study, we have found that miR-
324-3p could regulate the radioresistance of NPC cells 
and further confirmed WNT2B was the target gene of 
miR-324-3p [13]. Here, we focused on the roles of miR-
324-3p involved in NPC migration and invasion. Our 
results showed that miR-324-3p inhibited migration and 
invasion of NPC cells and affected epithelial-mesenchy-
mal transition (EMT) biomolecules, and the target gene 
WNT2B could enhance the migration and invasion abil-
ity of NPC. Currently, in NPC tissue specimens, miR-
324-3p was found to be downregulated while WNT2B 
was upregulated. Moreover, the expression levels of miR-
324-3p and WNT2B were associated with stages of NPC, 
as well as with lymph node metastasis. These results pro-
vide valuable clues toward understanding the molecular 
mechanisms of NPC migration and invasion.
Methods
Cell cultures
NPC cell lines 5-8F and 6-10B were purchased from 
the Cell Center of Central South University, Changsha, 
China. The cells were cultured in RPMI medium 1640 
(Hyclone, Logan, UT, USA) with 10% foetal bovine serum 
(Gibco BRL, Gaithersburg, MD, USA) and were incu-
bated at 37  °C in a humidified chamber with 5% CO2. 
Cells in an exponential growth state were used for subse-
quent experiments.
Patients and tissue preparation
Primary NPC (n = 39) and normal nasopharyngeal epi-
thelium (NPE) (n =  21) tissues were obtained from the 
the Department of Otolaryngology Head and Neck 
Surgery, Xiangya Hospital, Central South University, 
Changsha, China. All patients had no history of previ-
ous malignancies. Staging was performed by the 2008 
NPC staging system of China. The study protocol was 
approved by the Research Ethics Committee of the Cen-
tral South University, Changsha, China. Informed con-
sents were obtained from all of the patients.
Oligonucleotides and transfection
miR-324-3p mimics, WNT2B siRNA and negative con-
trol (NC) were chemically synthesized from Gene-
Pharma Co., Shanghai, China. The NPC cells 5-8F and 
6-10B were transfected with Lipofectamine 2000 reagent 
(Invitrogen, Burlington, ON, Canada) according to the 
manufacturer’s instructions. The transfection efficiency 
was observed by fluorescence microscopy, and the 
expression level of miR-324-3p and WNT2B were evalu-
ated using the qRT-PCR examination System (Bio-Rad, 
Hercules, CA, USA).
RNA extraction and quantitative real‑time PCR (qRT‑PCR) 
analyses
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) was used 
to extract the total RNA from NPC cells and tissues. The 
All-in-One™ miRNA qRT-PCR Detection Kit (GeneCo-
poeia Inc., MD, USA) was applied in reverse transcription 
and quantitative detection of miRNAs according to the 
user manual. The detection of mRNAs was carried out 
with TaqMan Reverse Transcription Reagents and SYBR 
Green PCR Master Mix (Applied Biosystems, CA, USA). 
PCR quantification was conducted using the 2−ΔΔCT 
method and normalized to U6 for miRNA or GAPDH for 
mRNA. The sequences of the primers used for the PCR 
are as follows: WNT2B forward, 5′-TGG CGT GCA CTC 
TCA GAT TT-3′ and reverse, 5′-GAC AAG ATC AGT 
CCG GGT GG-3′; GAPDH forward, 5′-TCC AAA ATC 
AAG TGG GGC GA-3′, and reverse, 5′-AGT AGA GGC 
AGG GAT GAT GT-3′. The technical documentation of 
qRT-PCR was listed in Additional file 1, and representa-
tive data of standard and melt curves of the premirs were 
listed in Additional file  2: Figure S1. And the validation 
of the stability of the reference genes between NPC and 
NPE was showed in Additional file 2: Figure S2.
Wound healing assay
Wound-healing assay was used to examine the cell 
migration activity. When the cells were grown to reach 
almost total confluence (nearly 36–48  h after transfec-
tion), a 10 μl plastic pipette tip was adopted to creat an 
artificial wound. Then the cells were cultured in serum-
free medium. The initial gap length (0 h) and the residual 
gap length 24–72 h after scratching were observed under 
the inverted microscope. Experiments were performed in 
triplicate.
Cell invasion assay
A transwell invasion assay was performed according 
to the operating instruction. Briefly, 1 ×  104 cells with 
serum-free medium were seeded to the top chamber 
with Matrigel-coated membrane (BD Biosciences, Bed-
ford, MA, USA). After a 48  h incubation period, non-
invading cells on the surface of the upper chamber were 
removed with a cotton swab. Cells on the lower side of 
the chamber were fixed in paraformaldehyde, stained 
with crystal violet, and then counted in five random 
fields under microscope. Each experiment was done 
three times.
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Western blotting analysis
Western blotting was carried out as described previ-
ously. Total cell or tissue proteins were extracted and 
separated on 10% SDS-PAGE gels, and electroblotted 
onto PVDF (polyvinylidene fluoride) membranes (Milli-
pore, Billerica, MA, USA). Then, the protein expression 
was detected by incubation with the relevant primary 
antibody followed by an appropriate secondary anti-
body. The primary antibody in current study included 
anti-WNT2B (1:800, Boiss Inc., Woburn, MA, USA), 
anti-E-cadherin and anti-Vimentin (1:800, Cell Signaling 
Technology, Danvers, MA, USA). Anti-β-Actin or anti-
GAPDH (1:1000, Beyotime, Shanghai, China) were used 
as the loading control. The relative expression of WNT2B 
protein was calculated by the image intensity of the ratio 
of WNT2B and β-Actin.
Statistical analysis
All data shown are representative results of at least 
three independent experiments and were expressed as 
mean  ±  standard deviation (SD). Statistical analyses 
were performed using a two-sided unpaired Student’s t 
test (for equal variances) or Mann–Whitney U test (for 
unequal variances) with SPSS 18.0 software. P < 0.05 was 
considered statistically significant.
Results
Ectopic expression of miR‑324‑3p inhibits migration 
and invasion of NPC cells
To investigate the role of miR-324-3p on NPC migra-
tion and invasion, we upregulated the expression of miR-
324-3p by transfecting miR-324-3p mimic into NPC 5-8F 
and 6-10B cells. A transfection efficiency of 93.8  ±  2.1 
and 92.7  ±  3.3% was observed under fluorescence 
microscopy in 5-8F and 6-10B cells, respectively, and 
the expression of miR-324-3p was successfully increased 
(P  <  0.01; Fig.  1a, b). The wound healing assay showed 
that cell migratory abilities of miR-324-3p overexpress-
ing cells were greatly inhibited compared with uninfected 
mock and control cells (P < 0.01, Fig. 1c, d). The transwell 
invasion assay showed that the number of invading cells 
was significantly decreased in miR-324-3p upregulated 
cells (P  <  0.01, Fig.  1e, f ). These results indicated that 
ectopic expression of miR-324-3p could inhibit migration 
and invasion of NPC cells.
Silencing expression of WNT2B suppresses migration 
and invasion of NPC cells
Our previous study had shown that WNT2B was the 
target gene of miR-324-3p, so we transfected WNT2B 
siRNA plasmids into NPC cells to confirm its role on 
migration and invasion of NPC. The expression of 
WNT2B was obviously decreased in 5-8F and 6-10B 
cells by qRT-PCR detection (Fig. 2a, b). The wound heal-
ing assay demonstrated that cell migration ability was 
inhibited when WNT2B was downregulated (P  <  0.01, 
Fig.  2c, d). The transwell invasion assay showed that 
the number of invading cells was significantly reduced 
in WNT2B siRNA transfected cells (P  <  0.01, Fig.  2e, 
f ). These data confirmed that the target gene WNT2B 
could also affect the migration and invasion of NPC 
cells.
miR‑324‑3p alters the expression of EMT biomarkers 
E‑cadherin and Vimentin
EMT was a classical mechanism of tumour invasion and 
metastasis, and we had confirmed that WNT2B could 
affect the expression of EMT biomarkers in previous 
study [14]. Here, we found following the upregulation 
of miR-324-3p in both NPC 5-8F and 6-10B cells, the 
expression of epithelial markers E-cadherin was upregu-
lated while mesenchymal markers Vimentin was down-
regulated (Fig.  3), which suggested that EMT might 
participate in the process of miR-324-3p mediated migra-
tion and invasion of NPC.
miR‑324‑3p is downregulated and its target gene WNT2B is 
upregulated in NPC specimens
We have validated that both miR-324-3p and target gene 
WNT2B could affect migration and invasion of NPC, 
so we further quantified the expressions of miR-324-3p 
and WNT2B in 39 freshly frozen NPC and 21 normal 
NPE tissues. The results showed that in NPC tissues, the 
expression of miR-324-3p was significantly decreased 
and both WNT2B mRNA and protein were upregulated 
(Fig. 4). And the expression of miR-324-3p was negative 
correlated with WNT2B mRNA and protein (Additional 
file 2: Figure S3).
Correlationship between miR‑324‑3p/WNT2B expression 
and clinicopathological parameters
The relationship between miR-324-3p/WNT2B expres-
sion and clinicopathological characteristics of NPC was 
explored. As summarized in Table  1, miR-324-3p lower 
expression was associated with tumour T classification, 
clinic stage and lymph node metastasis (P < 0.05), respec-
tively. And WNT2B mRNA/protein overexpression was 
also associated with tumour T classification, clinic stage 
and lymph node metastasis (P < 0.05). However, no sig-
nificant relationship existed between these markers and 
variables such as gender and age (P > 0.05). More expres-
sion data of NPE and NPC with two differential stratifica-
tions of T and clinic stage forms was shown in Additional 
file 2: Figure S4.
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Discussion
To understand the underlying molecular mechanisms 
involved in NPC migration and invasion is beneficial to 
develop better therapeutic strategies for NPC patients. 
Recently, as important regulatory factors, miRNAs have 
been shown to play crucial roles in various malignant 
biobehaviours of tumours, including NPC migration and 
invasion. Our previous study indicated that miR-324-3p 
could target WNT2B to affect the radioresistance of NPC 
in vitro [13]. In this study, we further demonstrated that 
miR-324-3p could also regulate the migration and inva-
sion of NPC, which contributes to illustrate the complex 
molecular mechanisms of migration and invasion in 
NPC.
miR-324-3p was located in the region of human chro-
mosome 17p13.1 and firstly identified in mammalian 
neurons [15]. Up to now, with the rapid development of 
microarray and sequencing technology, some researchers 
have found that miR-324-3p was dysregulated in a variety 
of tumours such as breast cancer [16], hepatocellular car-
cinoma [17] and pancreatic cancer [18]. However, none 
of these studies further explored the roles of miR-324-3p 
on tumour maglinant biobehaviours. More specifically, 
previous investigations into the function of miR-324-3p 
were limited, and only several reports showed miR-
324-3p was a target of ACE inhibition to promote renal 
fibrosis and miR-324-3p could target RelA promoter to 
induce its expression in an Ago2 dependent manner in 
cells of neural origin [19, 20]. Functional analyses of miR-
324-3p on tumour were just seen in our preceding study 
[13] and another similar report of NPC radioresistance, 
in which SMAD7 was validated as the target of miR-
324-3p [21]. In this study, we further confirmed the role 
of miR-324-3p on NPC migration and invasion, which 
suggests miR-324-3p as an anti-tumour miRNA.
miRNAs usually exert their function by interacting 
with their target genes via base pairing. In our previous 
research, we found that WNT2B was a direct target gene 
of miR-324-3p and confirmed WNT2B could affect radi-
oresistance of NPC cells [13]. WNT2B was known to stim-
ulate the canonical WNT/β-catenin pathway and affected 
various malignant tumour progression [22]. In head and 
Fig. 1 Ectopic expression of miR-324-3p inhibits migration and invasion of NPC cells. The transfection efficiency and expression of miR-324-3p 
were determined under fluorescent microscope and qRT-PCR in 5-8F (a) and 6-10B (b) cells. The migration of different cell groups was examined by 
wound healing experiments in 5-8F (c) and 6-10B (d) cells. The invasion of different cell groups was detected by transwell invasion assays in 5-8F (e) 
and 6-10B (f) cells. The results represent the average of three independent experiments ± standard deviation (S.D). (**P < 0.01)
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neck squamous cell carcinoma, WNT2B played a role in 
tumourigenesis and chemotherapy resistance in vivo and 
in  vitro [23]. Intratumoural WNT2B was reported to be 
correlated with the expression of Survivin and c-Myc, 
tumour proliferation and prognosis in malignant pleural 
mesothelioma [24]. Jiang et  al. also found that the high-
expression level of WNT2B was associated with the pro-
gression and worse outcome of pancreatic cancer [25]. 
In addition, WNT2B can increase the ability of metasta-
sis and chemoresistance of ovarian cancer through the 
caspase-9/BCL2/BCL-xL pathway and EMT/p-AKT 
pathways [26]. All these studies highlighted the role of 
WNT2B on tumour malignant processes. However, the 
function of WNT2B on NPC was only seen in our prelimi-
nary work, and here we further found that WNT2B played 
roles on migration and invasion of NPC, and revealed that 
both WNT2B mRNA and protein was positively corre-
lated with higher stages of NPC, which indicated the pos-
sibility of WNT2B to be the novel biomarker of NPC.
EMT was defined as a process that epithelial cells 
transformed into a mesenchymal phenotype, in which 
the expression of epithelial marker E-cadherin and 
Fig. 2 Silencing expression of WNT2B suppresses migration and invasion of NPC cells. WNT2B was successfully downregulated by WNT2B siRNA 
in 5-8F (a) and 6-10B (b) cells. The migration of different cell groups was examined by wound healing experiments in 5-8F (c) and 6-10B (d) cells. 
The invasion of different cell groups was examined using matrigel invasion assays in 5-8F (e) and 6-10B (f) cells. The results represent the average of 
three independent experiments ± standard deviation (S.D). (**P < 0.01)
Fig. 3 miR-324-3p alters the expression of EMT biomarkers E-cad-
herin and Vimentin. Following ectopic expression of miR-324-3p, 
the expression of E-cadherin was upregulated and Vimentin was 
downgrelated, shown by Western blotting
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mesenchymal marker Vimentin was considered as the 
classical indicators [27]. And EMT had been widely 
investigated to be classical mechanism of tumour inva-
sion and metastasis [27, 28]. Moreover, recent research-
ers reported that miR-544a could induce EMT through 
the activation of WNT signaling pathway in gastric can-
cer [29]. In other tumours such as ovarian [30], colorec-
tal [31] and tongue cancer [32], EMT was also associated 
with the activation of the WNT signalling pathway. With 
regard to NPC, we found that WNT2B was able to change 
the expression of E-cadherin and Vimentin [14]. In this 
study, we validated that miR-324-3p also had the abil-
ity of altering the expression of EMT biomarkers, which 
showed that miR-324-3p might regulate the migration 
and invasion of NPC through EMT.
In summary, we have demonstrated that miR-324-3p 
can target WNT2B to regulate migration and invasion 
in NPC, and both miR-324-3p and target gene WNT2B 
were associated with T stage, clinic stage and cervical 
lymph node metastasis. Therefore, miR-324-3p/WNT2B 
axis may be potential therapeutic target for the treatment 
of patients with NPC.
Conclusion
miR-324-3p is a tumor-suppressive miRNA in NPC 
and inhibit NPC cell migration and invasion by target-
ing WNT2B. Complete understanding of the miR-324-
3p/WNT2B pathway might contribute to discover new 
potential therapeutic clues for NPC.
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S2. Validation of the stability of the reference genes. (A) Amplification plot 
and CT values of U6 between NPC and NPE. (B) Amplification plot and CT 
values of GAPDH between NPC and NPE. Figure S3. Spearman correla-
tion analysis between the expression of miR-324-3p and WNT2B. (A) miR-
324-3p was negative correlated with WNT2B mRNA. (B) miR-324-3p was 
negative correlated with WNT2B protein. Figure S4. The expression data 
of NPE and NPC with two differential stratifications of T and clinic stage 
forms. (A) The expression of miR-324-3p between NPE and NPC. (B) The 
expression of WNT2B mRNA between NPE and NPC. (C) The expression of 
WNT2B mRNA between NPE and NPC.
Fig. 4 The expression of miR-324-3p and WNT2B in NPC specimens. a miR-324-3p was downregulated in NPC tissues compared with NPE tissues. 
b WNT2B mRNA was upregulated in NPC tissues compared with NPE tissues. c WNT2B protein was upregulated in NPC tissues compared with NPE 
tissues. miR-324-3p, WNT2B mRNA and protein were normalized with the internal control U6, GAPDH and β-Actin, respectively. (**P < 0.01)
Table 1 Clinicopathological features of the cases of NPC
Data was shown as mean ± SD. miR-324-3p, WNT2B mRNA and protein were 
normalized with the internal control U6, GAPDH and β-Actin, respectively
* P < 0.05
** P < 0.01
Variables Cases miRNA‑324‑3p WNT2B mRNA WNT2B protein
Sex
 Male 28 0.717 ± 0.463 1.028 ± 0.461 1.001 ± 0.369
 Female 11 0.613 ± 0.245 1.052 ± 0.305 1.010 ± 0.320
Age
 <45 19 0.731 ± 0.386 1.055 ± 0.372 1.008 ± 0.301
 ≥45 20 0.647 ± 0.443 1.016 ± 0.468 0.999 ± 0.402
T stage
 T3 + T4 9 0.476 ± 0.296 1.306 ± 0.324 1.312 ± 0.340
 T1 + T2 30 0.751 ± 0.426* 0.953 ± 0.414* 0.911 ± 0.303**
Clinic stage
 III + IV 23 0.466 ± 0.283 1.237 ± 0.341 1.199 ± 0.304
 I + II 16 1.006 ± 0.362** 0.743 ± 0.347** 0.722 ± 0.187**
Lymph node metastasis
 Yes 28 0.539 ± 0.324 1.171 ± 0.316 1.099 ± 0.284
 No 11 1.067 ± 0.381** 0.687 ± 0.461** 0.761 ± 0.403*
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